Glycobiology Market to Witness Significant Growth During Next Five Years
Growing proteomics and
glycomics industry to drive the growth of global glycobiology market
According to TechSci Research report, “Global Glycobiology
Market By Type of Enzyme (Glycosidases & Neuramidases,
Glycosyltransferases & Sialytransferases, Carbohydrate kinases,
Carbohydrate Sulfotransferases, Protein Sulfotransferases, Others), By Type of Kit (Glycan Releasing Kit, Glycan
Labelling Kit, Glycan Purification Kit, Others), By Application (Drug
Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology, Others), By
End User (Research Institutes, Diagnostic Centers, Hospitals, Clinical
Laboratories, Pharmaceutical & biotechnology companies, Others), By Region,
Forecast & Opportunities, 2025”, the global glycobiology market is expected to grow at a formidable
rate during the forecast period on account of the increasing R&D activities
related to glycomics and proteomics. Additionally, ongoing technological
advancements especially in the instrumentations and kits used in glycobiology
technique coupled with the novel product launches by the major players operating
in the market is further expected to propel the market during forecast period.
Also, the use of glycobiology in the anti-cancer drug discovery is anticipated
to spur the growth of market over the next few years. Furthermore, the use of
glycomics in the field of dermatology for studying the aging pattern of the
skin is expected to positively impact the growth of market through 2025. Also,
synthesis, differentiation and proliferation of skin can be achieved using
glycobiology thereby increasing its application in tissue architecture.
However, high costs of the instrumentation, tools or kits used in the technique
make it expensive which can hamper the growth of market during forecast period.
Additionally, stringent government policies also hinder the market growth.
Moreover, the technique requires skilled personnel to perform it and lack of
such skilled people might impede the growth of market over the next few years.
Browse
XX market data Tables and XX Figures spread through XXX
Pages and an in-depth TOC on" Global
Glycobiology Market"
https://www.techsciresearch.com/report/glycobiology-market/4635.html
The global glycobiology market is segmented based on type of enzyme,
type of kit, application, end user, company and region. Based on the type of
kit, the market can be categorized into glycan releasing kit, glycan labelling
kit, glycan purification kit and others. The glycan releasing kit segment is
expected to dominate the market since these kits are applicable for different
enzymes such as glycosyltransferases, sialyltransferases, sulfotransferases,
among others that generate leaving groups with a removable phosphate.
Additionally, these kits are quantitative, convenient and amenable to high
throughput analysis. Based on application, the market can be fragmented into drug
discovery, disease diagnostics, virology, cell biology, oncology and others.
The drug discovery segment is expected to dominate the market on account of the
increasing demand for personalized medicines. Additionally, increasing R&D
activities by the major players operating in the market and different
governments around the globe for the development of novel therapeutics is further
anticipated to drive the growth of this segment during the next five years.
Based on end user, the market can be grouped into research institutes,
diagnostic centers, hospitals, clinical laboratories, pharmaceutical &
biotechnology companies and others. The pharmaceutical & biotechnology
companies segment is expected to register highest CAGR during the forecast
period. This can be accredited to the growing demand for new drug discovery and
development especially for treatment of chronic diseases such as diabetes, cancer,
among others.
Merck & Co., Inc., Agilent
Technologies, Inc., Thermo Fisher Scientific, New England Biolabs, Inc.,
Shimadzu Corporation, Takara Bio Inc., Waters Corporation, Asparia Glycomics
S.L., Bruker Corporation, RayBiotech, Inc., Z Biotech, LLC., Chemily
Glycoscience, Dextra Laboratories Ltd., Lectenz Bio, Ludger Ltd, R&D
Systems, Inc., Bio-Techne, Danaher Corporation, S-BIO (subsidiary of Sumitomo
Bakelite Co. Ltd., Japan), ProZyme and others are some of the leading
players operating in global glycobiology market. The companies
operating in the market are using organic strategies such as product launches,
mergers and collaborations to boost their share. For instance, in June 2019,
Agilent Technologies (US) launched InfinityLab LC/MSD iQ System.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4635
Customers can also request for 10% free customization on
this report.
“Europe is expected to register
significant growth in the glycobiology market during the forecast period, owing
to the increasing funding on glycomics research, rising R&D expenditure for
drug discovery & development, among others. Additionally, increasing number
of biopharmaceutical and pharmaceutical companies in the region is further
expected to create lucrative opportunities for the market players over the next
few years.” said
Mr. Karan Chechi, Research Director with TechSci Research, a research based
global management consulting firm.
“Global Glycobiology Market By Type of Enzyme
(Glycosidases & Neuramidases, Glycosyltransferases & Sialytransferases,
Carbohydrate kinases, Carbohydrate Sulfotransferases, Protein
Sulfotransferases, Others), By
Type of Kit (Glycan Releasing Kit, Glycan Labelling Kit, Glycan Purification
Kit, Others), By Application (Drug Discovery, Disease Diagnostics, Virology,
Cell Biology, Oncology, Others), By End User (Research Institutes, Diagnostic
Centers, Hospitals, Clinical Laboratories, Pharmaceutical & biotechnology
companies, Others), By Region, Forecast & Opportunities, 2025”,” has evaluated the future growth potential of global glycobiology
market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in global glycobiology market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]